BIOREGENX, INC. (BRGX) Free cash flow 2023–2025
BIOREGENX, INC. (BRGX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$29,915FY2025 · since FY2023: -$1.5M → $29,915
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29,915 | +105.8% |
| FY2024 | -$513,538 | +66.1% |
| FY2023 | -$1.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRGX financial trends
BRGX RevenueBRGX Net incomeBRGX Net marginBRGX Gross profitBRGX Gross marginBRGX Operating incomeBRGX Operating marginBRGX Operating cash flowBRGX Capital expendituresBRGX Return on equityBRGX Stock buybacksBRGX Dividends paidBRGX Total assetsBRGX Total liabilitiesBRGX Shareholders’ equityBRGX overview →